first generic glp 1 of Once-Daily GLP-1 Injection Approved for Diabetes Canada has become the first

For the research frontier of metabolic peptide therapy, retatrutide is the winner

9 Behavior change combined with GLP-1s drives lasting weight loss

Inflammation 44 , 10691082 (2021)

Neural Plast 2016:2585230 Morken TS, Brekke E, Haberg A, Wideroe M, Brubakk AM, Sonnewald U (2014) Altered astrocyte-neuronal interactions after hypoxia-ischemia in the neonatal brain in female and male rats

Mast Cell Activation Syndrome Mast Cell Activation Syndrome, or MCAS, is a related but distinct condition in which mast cells immune cells that release histamine and other inflammatory chemicals become inappropriately activated, releasing excessive amounts of these mediators in response to triggers that would not normally cause a reaction

This disparity underscores a critical knowledge gap that must be resolved before confident, evidence-based clinical adoption can be justified